Reaction Details |
![](/images/Email.png) | Report a problem with these data |
Target | Lysine-specific histone demethylase 1A |
---|
Ligand | BDBM425103 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Biological Activity Assay |
---|
IC50 | 800±n/a nM |
---|
Citation | Rienhoff, Jr., HY; McCall, JM; Clare, M; Celatka, C; Tapper, AE KDM1A inhibitors for the treatment of disease US Patent US11230534 Publication Date 1/25/2022 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Lysine-specific histone demethylase 1A |
---|
Name: | Lysine-specific histone demethylase 1A |
Synonyms: | AOF2 | BRAF35-HDAC complex protein BHC110 | Flavin-containing amine oxidase domain-containing protein 2 | KDM1 | KDM1A | KDM1A_HUMAN | KIAA0601 | LSD1 | Lysine-specific demethylase 1 (LSD1) | Lysine-specific histone demethylase 1 | Lysine-specific histone demethylase 1 (LSD1) |
Type: | Enzyme |
Mol. Mass.: | 92901.01 |
Organism: | Homo sapiens (Human) |
Description: | O60341 |
Residue: | 852 |
Sequence: | MLSGKKAAAAAAAAAAAATGTEAGPGTAGGSENGSEVAAQPAGLSGPAEVGPGAVGERTP
RKKEPPRASPPGGLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTSRRKRAKVEY
REMDESLANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESEPEEPSGVEGAAFQ
SRLPHDRMTSQEAACFPDIISGPQQTQKVFLFIRNRTLQLWLDNPKIQLTFEATLQQLEA
PYNSDTVLVHRVHSYLERHGLINFGIYKRIKPLPTKKTGKVIIIGSGVSGLAAARQLQSF
GMDVTLLEARDRVGGRVATFRKGNYVADLGAMVVTGLGGNPMAVVSKQVNMELAKIKQKC
PLYEANGQAVPKEKDEMVEQEFNRLLEATSYLSHQLDFNVLNNKPVSLGQALEVVIQLQE
KHVKDEQIEHWKKIVKTQEELKELLNKMVNLKEKIKELHQQYKEASEVKPPRDITAEFLV
KSKHRDLTALCKEYDELAETQGKLEEKLQELEANPPSDVYLSSRDRQILDWHFANLEFAN
ATPLSTLSLKHWDQDDDFEFTGSHLTVRNGYSCVPVALAEGLDIKLNTAVRQVRYTASGC
EVIAVNTRSTSQTFIYKCDAVLCTLPLGVLKQQPPAVQFVPPLPEWKTSAVQRMGFGNLN
KVVLCFDRVFWDPSVNLFGHVGSTTASRGELFLFWNLYKAPILLALVAGEAAGIMENISD
DVIVGRCLAILKGIFGSSAVPQPKETVVSRWRADPWARGSYSYVAAGSSGNDYDLMAQPI
TPGPSIPGAPQPIPRLFFAGEHTIRNYPATVHGALLSGLREAGRIADQFLGAMYTLPRQA
TPGVPAQQSPSM
|
|
|
BDBM425103 |
---|
n/a |
---|
Name | BDBM425103 |
Synonyms: | N-((S)-5-((1R,2S)-2-(4- fluorophenyl)cyclopropylamino)-1-(4- (methylsulfonyl)piperazin-1-yl)-1- oxopentan-2-yl)-4-(1H-pyrazol-1- yl)benzamide | US10519118, Example 178 | US11230534, Example 178 |
Type | Small organic molecule |
Emp. Form. | C29H35FN6O4S |
Mol. Mass. | 582.689 |
SMILES | CS(=O)(=O)N1CCN(CC1)C(=O)[C@H](CCCN[C@@H]1C[C@H]1c1ccc(F)cc1)NC(=O)c1ccc(cc1)-n1cccn1 |r| |
Structure |
|